Effect of Danhong injection on neurological recovery and adverse events in patients with acute ischemic stroke: A protocol for a randomized, double-blind, placebo-controlled clinical study

BACKGROUND: Acute ischemic stroke (AIS) is characterized by high disabling and recurrent recurrence, and its severe neurological impairment and vascular adverse events (AEs) limit the recovery of patients. Danhong injection is a complementary alternative to the treatment of AIS, and previous studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Junfeng, Shao, Xiangzhong, Guan, YiXiang, Mei, Juxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601334/
https://www.ncbi.nlm.nih.gov/pubmed/34797293
http://dx.doi.org/10.1097/MD.0000000000027683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601334/
https://www.ncbi.nlm.nih.gov/pubmed/34797293
http://dx.doi.org/10.1097/MD.0000000000027683

Ejemplares similares